Tower Research Capital (TRC)’s Global X China Biotech Innovation ETF CHB Stock Holding History

Tower Research Capital (TRC)’s Portfolio CHB Stock Details CHB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1	Closed	–	–	6500
2022 Q4	$0	Buy	+1	New	+$9	﹤0.01%	6578

Other funds holding CHB

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Tower Research Capital (TRC)'s CHB Position: Q1 2023 in Review

Tower Research Capital (TRC) sold out of Global X China Biotech Innovation ETF (CHB) in Q1 2023, closing a stake of 1 share.

Tower Research Capital (TRC) first reported a position in CHB in Q4 2022 and held it in 1 quarter. The position peaked at $0 in Q4 2022. 2 funds tracked by Wall St. Rank hold CHB as of Q1 2023.

Tower Research Capital (TRC) reported no remaining Global X China Biotech Innovation ETF position as of Q1 2023 after selling out during the quarter.
Tower Research Capital (TRC) sold 1 Global X China Biotech Innovation ETF share in Q1 2023.
Tower Research Capital (TRC) first reported a position in Global X China Biotech Innovation ETF in Q4 2022 and held it in 1 quarter.
Tower Research Capital (TRC)'s Global X China Biotech Innovation ETF position peaked at $0 in Q4 2022.
2 funds tracked by Wall St. Rank held Global X China Biotech Innovation ETF as of Q1 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.